CompanyProductsScienceSupportWhatsnew
[Product Releases]
Index
[Blog]

Most recent post

[News]

Can we trust docking results?
Sept 2010

IBM Systems and Technology Group releases a white paper with eHiTS and Cell
Oct 2008

EPA's ToxCastTM project will use SimBioSys' eHiTS as docking engine
Nov, 2007

[Events]

243rd ACS
Mar 25-29, 2012
San Diego, CA
see >> more

Index

Company Info

SimBioSys® is a recognized leader in the field of rational drug discovery software. Providing a wide range of software solutions, the company is focused on the development of scientific tools to facilitate the drug discovery process. It retains a constant focus on the innovation of algorithms to provide improved throughput and accuracy in the fields of flexible docking, virtual screening and de-novo structure design. SimBioSys is also a pioneer in the field of computer-aided retrosynthetic analysis where it supports chemists through the challenges of organic synthesis. With attention to detail, ease-of-use and improved productivity, SimBioSys has built a strong reputation of delivering state-of-the-art scientific solutions to biotechnology and pharmaceutical companies.

Background

SimBioSys Inc. was incorporated in 1996 as a side venture fom the Institute for Computer Appliactions in Molecular Sciences (ICAMS) at the University of Leeds, UK.

Since becoming incorporated, the first 4 years were devoted to the development of technology infrastructure MoDeST (Molecular Design Software Toolkit). The next years were focused on application development and today SimBioSys is ready to market new products such as eHiTS, LASSO, ARChem etc. all developed on its molecular modelling platform: MoDeST

Company Profile

SimBioSys develops 3-dimensional molecular modelling software for the pharmaceutical drug discovery industry. 

The products and services are developed with the following goals in mind:
  • acceleration of the drug discovery process
  • increasing the speed and accuracy of drug R&D
  • increasing the quality of research decisions

The Company's Vision

SimBioSys envisions being a leader in providing the highest quality and performance interactive visual design software for the biomolecular sciences.

The company's aim revolves around its mission statement:  Reality3 - to be realistic in all three dimensions:
  • fully interactive real-time software
  • using realistic scientific simulations
  • packaged together to provide the most realistic visualization possible.



Copyright © 2011 SimBioSys Inc., All rights reserved.